George Fountzilas Selected Research

George Fountzilas Research Topics

Disease

137	Neoplasms (Cancer) 11/2023 - 04/2003
93	Breast Neoplasms (Breast Cancer) 12/2023 - 06/2003
28	Carcinoma (Carcinomatosis) 01/2023 - 08/2002
26	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2005
17	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2005
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 09/2002
12	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 05/2003
12	Disease Progression 03/2020 - 06/2003
10	Nasopharyngeal Carcinoma 01/2023 - 04/2005
9	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2005
8	Melanoma (Melanoma, Malignant) 01/2016 - 04/2003
7	Adenocarcinoma 06/2021 - 01/2005
7	Stomach Neoplasms (Stomach Cancer) 06/2021 - 10/2004
7	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 01/2004
7	Colonic Neoplasms (Colon Cancer) 12/2019 - 08/2002
7	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 11/2006
5	Febrile Neutropenia 07/2015 - 06/2004
5	Ovarian Epithelial Carcinoma 03/2007 - 01/2004
4	Triple Negative Breast Neoplasms 03/2021 - 01/2016
4	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 07/2008
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 10/2008
4	Neutropenia 07/2015 - 08/2002
4	Laryngeal Neoplasms (Laryngeal Cancer) 11/2014 - 11/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 04/2019 - 09/2009
3	Glioma (Gliomas) 09/2018 - 04/2013
3	Infections 09/2017 - 01/2003
3	Brain Neoplasms (Brain Tumor) 09/2017 - 09/2005

Drug/Important Bio-Agent (IBA)

45	ParaffinIBA 11/2021 - 11/2005
40	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2007
37	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2005
34	Messenger RNA (mRNA)IBA 01/2022 - 01/2005
31	Formaldehyde (Formol)FDA Link 03/2021 - 08/2008
31	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 09/2002
23	Trastuzumab (Herceptin)FDA Link 10/2022 - 06/2003
20	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2005
18	AnthracyclinesIBA 01/2022 - 01/2004
18	Fluorouracil (Carac)FDA LinkGeneric 06/2021 - 08/2002
16	Docetaxel (Taxotere)FDA Link 12/2023 - 07/2003
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 03/2005
16	Carboplatin (JM8)FDA LinkGeneric 10/2016 - 09/2002
15	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 04/2005
13	Gemcitabine FDA Link 02/2020 - 09/2002
11	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 05/2003
11	PlatinumIBA 12/2022 - 01/2004
11	Leucovorin (Folinic Acid)FDA Link 12/2019 - 08/2002
11	Irinotecan (Camptosar)FDA LinkGeneric 12/2019 - 07/2005
11	Estrogen ReceptorsIBA 01/2018 - 07/2009
10	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 02/2006
10	human ERBB2 proteinIBA 10/2022 - 06/2012
10	Monoclonal AntibodiesIBA 11/2018 - 08/2002
9	Phenobarbital (Luminal)FDA Link 12/2022 - 02/2013
9	Taxoids (Taxanes)IBA 01/2022 - 07/2003
9	Bevacizumab (Avastin)FDA Link 04/2020 - 02/2010
9	Hormones (Hormone)IBA 01/2020 - 06/2006
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2019 - 01/2005
9	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 07/2009
9	Cetuximab (Erbitux)FDA Link 06/2015 - 08/2008
8	taxaneIBA 01/2020 - 01/2004
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 02/2004
7	Capecitabine (Xeloda)FDA Link 05/2018 - 01/2005
7	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 12/2003
7	Vascular Endothelial Growth Factor CIBA 01/2018 - 11/2006
7	RNA (Ribonucleic Acid)IBA 07/2015 - 11/2006
6	LigandsIBA 01/2022 - 06/2012
6	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2005
6	Epidermal Growth Factor (EGF)IBA 01/2021 - 07/2007
6	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2006
6	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 11/2006
6	Cyclin D1IBA 01/2019 - 01/2013
6	Cadherins (E-Cadherin)IBA 05/2016 - 07/2007
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 07/2005
5	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 05/2020 - 05/2014
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2010 - 07/2005
5	liposomal doxorubicin (Doxil)FDA Link 01/2010 - 06/2004
4	CateninsIBA 01/2018 - 10/2013
4	InterferonsIBA 01/2016 - 02/2006
4	Thymidylate SynthaseIBA 09/2014 - 07/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013 - 01/2007
4	Sunitinib (Sutent)FDA Link 08/2013 - 09/2009
4	Gefitinib (Iressa)FDA Link 01/2010 - 07/2005
3	Immune Checkpoint InhibitorsIBA 06/2023 - 02/2015
3	Protein Isoforms (Isoforms)IBA 04/2021 - 10/2014
3	Androgen Receptors (Androgen Receptor)IBA 03/2021 - 06/2014
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 01/2006
3	ChemokinesIBA 01/2020 - 06/2012
3	TOR Serine-Threonine KinasesIBA 04/2019 - 07/2014
3	Somatomedin Receptors (Somatomedin Receptor)IBA 11/2018 - 01/2013
3	Growth Factor ReceptorsIBA 12/2016 - 11/2007
3	XELOXIBA 01/2016 - 01/2005
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2014 - 07/2007

Therapy/Procedure

84	Drug Therapy (Chemotherapy) 12/2023 - 08/2002
39	Therapeutics 01/2022 - 09/2003
38	Adjuvant Chemotherapy 01/2023 - 01/2005
19	Radiotherapy 01/2023 - 05/2003
8	Chemoradiotherapy 01/2023 - 01/2004
5	Induction Chemotherapy 01/2023 - 04/2005
5	Immunotherapy 01/2022 - 02/2006
3	Aftercare (After-Treatment) 01/2023 - 05/2003
3	Semiconductors 05/2016 - 01/2015
3	Treatment Delay 07/2015 - 01/2009